|
Match
|
Document |
Document Title |
|
|
US20090280173 |
Multilayer Omeprazole Tablets
Multilayer tablets of Omeprazole and/or a salt thereof essentially bioequivalent in terms of plasma Omeprazole C max and AUC to Omeprazole capsules and/or Omeprazole Magnesium tablets consisting...
|
|
|
US20090238868 |
ABUSE-RESISTANT ORAL DOSAGE FORMS AND METHOD OF USE THEREOF
An opioid-antagonist oral dosage form which does not release a therapeutically effective amount of the opioid antagonist when the oral dosage form is orally administered to a human being, but...
|
|
|
US20090169622 |
DELAYED-RELEASE ORAL PHARMACEUTICAL COMPOSITION FOR TREATMENT OF COLONIC DISORDERS
A timed or delayed release oral composition delivery system for the treatment of colonic disorders and diseases is provided. According to one aspect, a delayed release oral pharmaceutical...
|
|
|
US20090130206 |
Controlled Release Compositions of an Antidepressant Agent
The present invention relates to controlled release compositions comprising an anti-depressant compound. More particularly, the present invention relates to controlled release compositions...
|
|
|
US20090041840 |
Positive wakeup pharmaceutical sleep system with compatible pre-bedtime administration
A novel sleep regulating pharmaceutical formulation is introduced, typically implementing two principal drugs having actions which are reversive to one another, yet incorporated into a unitary...
|
|
|
US20090022797 |
Stabilized tolterodine tartrate formulations
A pharmaceutical composition contains tolterodine L-tartrate stabilized against degradation with an acid. Acid-stabilized tolterodine L-tartrate may be used to make various types of immediate...
|
|
|
US20080220061 |
System for manufacturing controlled release dosage forms, such as zero-order release profile dosage form manufactured by three-dimensional printing
The present invention includes controlled release dosage forms and methods of designing and manufacturing dosage forms to obtain specific release profiles, for example, zero-order release profiles,...
|
|
|
US20080166405 |
Abuse-resistant oral dosage forms and method of use thereof
An opioid-antagonist oral dosage form which does not release a therapeutically effective amount of the opioid antagonist when the oral dosage form is orally administered to a human being, but...
|
|
|
US20080038348 |
MODIFIED RELEASE FORMULATIONS OF A BUPROPION SALT
The present invention relates to pharmaceutical compositions, formulations and medicaments comprising a bupropion salt, in particular, modified-release tablets comprising an effective amount of...
|